Search

Your search keyword '"CoMSIA"' showing total 218 results

Search Constraints

Start Over You searched for: Descriptor "CoMSIA" Remove constraint Descriptor: "CoMSIA" Publisher springer nature Remove constraint Publisher: springer nature
218 results on '"CoMSIA"'

Search Results

1. Hybrid 2D/3D-quantitative structure–activity relationship studies on the bioactivities and molecular mechanism of antibacterial peptides.

2. 3D quantitative structure–activity relationships study on anti-gastric cancer of chrysin derivatives.

3. Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophrenia.

4. In silico design of antimicrobial oligopeptides based on 3D-QSAR modeling and bioassay evaluation.

5. Molecular modelling of quinoline derivatives as telomerase inhibitors through 3D-QSAR, molecular dynamics simulation, and molecular docking techniques.

6. New molecular insights into dual inhibitors of tankyrase as Wnt signaling antagonists: 3D-QSAR studies on 4H-1,2,4-triazole derivatives for the design of novel anticancer agents.

7. Insight into structural requirements of ACE inhibitory dipeptides: QSAR and molecular docking studies.

8. Quantitative structure-activity relationship models for bitter-tasting tripeptides based on integrated descriptors.

9. Synthesis of 1,2,4-oxadiazole derivatives: anticancer and 3D QSAR studies.

10. Structural characterization of plasmodial aminopeptidase: a combined molecular docking and QSAR-based in silico approaches.

11. Understanding the structural features of JAK2 inhibitors: a combined 3D-QSAR, DFT and molecular dynamics study.

12. Macrocyclic effect on inhibitory activity: a modeling study on MerTK inhibitors.

13. In silico prediction of estrogen receptor subtype binding affinity and selectivity using 3D-QSAR and molecular docking.

14. Designing of novel ERRγ inverse agonists by molecular modeling studies of docking and 3D-QSAR on hydroxytamoxifen derivatives.

15. 3D-QSAR modeling of Phosphodiesterase-5 inhibitors: evaluation and comparison of the receptor- and ligand-based alignments.

17. 3D QSAR Modeling and Molecular Docking Studies on a Series of Triazole Analogues as Antibacterial Agents.

18. Exploration of structural and physicochemical properties of small molecules to inhibit NMDA functionality.

19. Multiple-receptor conformation docking, dock pose clustering, and 3D QSAR-driven approaches exploring new HIV-1 RT inhibitors.

20. CoMFA and CoMSIA-based designing of resveratrol derivatives as amyloid-beta aggregation inhibitors against Alzheimer's disease.

21. Exploring in house glutamate inhibitors of matrix metalloproteinase-2 through validated robust chemico-biological quantitative approaches.

22. An integrated ligand-based modelling approach to explore the structure-property relationships of influenza endonuclease inhibitors.

23. In silico studies on 2-substituted phenol quinazoline derivatives as RET receptor tyrosine kinase antagonists.

24. Computational Analysis of Artimisinin Derivatives on the Antitumor Activities.

25. In silico screening for identification of pyrrolidine derivatives dipeptidyl peptidase-IV inhibitors using COMFA, CoMSIA, HQSAR and docking studies.

26. Probing the structural requirements for thyroid hormone receptor inhibitory activity of sulfonylnitrophenylthiazoles (SNPTs) using 2D-QSAR and 3D-QSAR approaches.

27. Combined 3D-QSAR modeling and molecular docking study on spiro-derivatives as inhibitors of acetyl-CoA carboxylase.

28. Docking and three-dimensional quantitative structure-activity relationship analyses of imidazole and thiazolidine derivatives as Aurora A kinase inhibitors.

29. Determination of structural requirements of Mer kinase inhibitors and binding interaction analysis using in silico approaches.

30. Genotoxicity of quinolone antibiotics in chlorination disinfection treatment: formation and QSAR simulation.

31. 3D-QSAR studies on disubstituted dibenzosuberone derivatives as p38α MAP kinase inhibitors using CoMFA and COMSIA.

32. 3D-QSAR studies on lipid peroxidation inhibitory activity of chromone derivatives.

33. Development of Quantitative Structure-Activity Relationship Models for Predicting Chronic Toxicity of Substituted Benzenes to Daphnia Magna.

34. Design and prediction of new acetylcholinesterase inhibitor via quantitative structure activity relationship of huprines derivatives.

35. Molecular modeling studies on series of Btk inhibitors using docking, structure-based 3D-QSAR and molecular dynamics simulation: a combined approach.

36. CoMFA and CoMSIA studies on 6,7-disubstituted-4-phenoxyquinoline derivatives as c-Met kinase inhibitors and anticancer agents.

37. Molecular modeling study on Mer kinase inhibitors using 3D-QSAR and docking approaches.

38. 3D-QSAR study of tetrahydro-3 H-imidazo[4,5- c]pyridine derivatives as VEGFR-2 kinase inhibitors using various charge schemes.

39. 3D-QSAR and docking studies on piperidine-substituted diarylpyrimidine analogues as HIV-1 reverse transcriptase inhibitors.

40. 3D QSAR modeling study on 7-aminofuro [2,3-c] pyridine derivatives as TAK1 inhibitors using CoMFA and COMSIA.

41. Pharmacophore modeling, virtual screening, and 3D-QSAR studies on a series of non-steroidal aromatase inhibitors.

42. 3D-QSAR studies of 8-substituted chromen-4-one-2-carboxylic acid derivatives as potent agonists for the orphan G protein-coupled receptor 35.

43. Two- and three-dimensional quantitative structure-permeability relationship of flavonoids in Caco-2 cells using stepwise multiple linear regression (SMLR), partial least squares regression (PLSR), and pharmacophore (GALAHAD)-based comparative molecular similarity index analysis (COMSIA)

44. 3D-QSAR and docking study on 3-benzimidazol-2-ylhydroquinolin-2-one derivatives as VEGFR-2 tyrosine kinase inhibitors.

45. Atom-based QSAR and 3D QSAR using pharmacophore based alignment for discovery of nimesulide-derived SKBR-3 cell line inhibitors.

46. 3D-QSAR studies of dipeptidyl peptidase-4 inhibitors using various alignment methods.

47. 3D-QSAR modeling and molecular docking study on Mer kinase inhibitors of pyridine-substituted pyrimidines.

48. Pharmacophore modeling, 3DQSAR, and docking-based design of polysubstituted quinolines derivatives as inhibitors of phosphodiesterase 4, and preliminary evaluation of their anti-asthmatic potential.

49. Computational insights into the active site of human breast cancer resistance protein (BCRP/ABCG2): a similarity search approach.

50. Docking, CoMFA, and CoMSIA analyses of phenoxy triazole derivatives as enoyl-ACP reductase inhibitors for Escherichia coli.

Catalog

Books, media, physical & digital resources